Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2011

Rectiv(Nitroglycerin)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$2.2M

Medicare cost, 2024

Medicare drug plans spent $2.2 million on Rectiv (nitroglycerin) in 2024, for 3,206 prescriptions and refills filled by 1,834 patients. Spending fell 63% from 2023 to 2024. New York accounts for the most spending ($479,433, 22% of the total).

Medicare cost, 2024

$2.2M

-63.0% from 2023

Prescriptions

3,206

$671.17 per claim

Patients

1,834

1,699 prescribers

Total spending, 2024

$2.2M

$1,176.84 per patient

Questions and answers

How much does Medicare spend on Rectiv?

Medicare prescription drug plans paid $2.2M for Rectiv in 2024, for 3,206 prescriptions and refills to 1,834 patients (down 63.0% from 2023). The average cost per claim was $671.17.

Which state spends the most on Rectiv?

New York had the highest Medicare cost for Rectiv in 2024: $479K for 740 claims, followed by New Jersey ($233K).

Who prescribes Rectiv the most?

Sixto R Caro, internal medicine in Brooklyn, NY, had the highest Medicare cost for Rectiv in 2024: 39 claims costing $32K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Rectiv was $2.2M in 2024, after a high of $5.8M in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Rectiv, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Sixto R Caro Brooklyn, NYInternal Medicine39Under 11$32K
1699742932 Internal Medicine50Under 11$29K
Ghias Moussa Jersey City, NJCardiology30Under 11$26K
Housein M Wazaz Meriden, CTGastroenterology3820$25K
Mara Khaylomskaya New York, NYInternal Medicine40Under 11$24K
Valerija Shvartsman Bronx, NYNurse Practitioner35Under 11$21K
Alexander Shekhter Brooklyn, NYInternal Medicine22Under 11$20K
Alaa S Eldin Jersey City, NJGastroenterology12Under 11$18K
Ahab Gabriel East Brunswick, NJInternal Medicine28Under 11$16K
Konstantin Peysin Brooklyn, NYInternal Medicine23Under 11$14K
Heather L Rossi Coon Rapids, MNColorectal Surgery (Proctology)1911$12K
Zinovy N Lekht Sun Valley, CAInternal Medicine17Under 11$11K
Oleksandr Seleverstov College Place, WAInternal Medicine12Under 11$11K
Michael Nemirovsky Utica, NYFamily Practice12Under 11$10K
Anatole Barkan Brooklyn, NYInternal Medicine17Under 11$10K
Jee Hoon Jang Simi Valley, CAInternal Medicine16Under 11$10K
Khalil Innabi Yonkers, NYFamily Practice12Under 11$9,352
Jacob V George Brooklyn, NYInternal Medicine12Under 11$8,994
Scott Suchin Bronx, NYGastroenterology15Under 11$8,994
Aleksandr Zasypkin Brooklyn, NYInternal Medicine13Under 11$8,155
Nirish S Shah Roanoke, VAGastroenterology13Under 11$8,011
Murali M Alloju Frisco, TXGastroenterology13Under 11$8,003
Aria Behrouzi Christiansburg, VAFamily Practice11Under 11$8,001
Sujithraj Dommaraju Ithaca, NYInternal Medicine12Under 11$7,961
Jennifer L Geremia Cranston, RIPhysician Assistant13Under 11$7,795

Prescriber data by year

YearPrescribersClaimsPatientsCost
20223,9517,1584,409$5.2M
20234,5328,1595,040$5.8M
20241,6993,2061,834$2.2M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Aptalis/Allerga3,218$2.2M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
1
RxNorm concept IDs
1114466, 1114470
Application numbers
NDA021359

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube